Cargando...
Mass spectrometry imaging to detect lipid biomarkers and disease signatures in cancer
BACKGROUND: Current methods to identify, classify, and predict tumor behavior mostly rely on histology, immunohistochemistry, and molecular determinants. However, better predictive markers are required for tumor diagnosis and evaluation. Due, in part, to recent technological advancements, metabolomi...
Guardado en:
| Publicado en: | Cancer Rep (Hoboken) |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7941519/ https://ncbi.nlm.nih.gov/pubmed/32729258 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cnr2.1229 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|